Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 10 Million Shares of its Common Stock

NEXT STORY
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector
PREV STORY
TFF Pharmaceuticals Announces Completion of Dosing of Phase 1b Study for Voriconazole Inhalation Powder in Mild to Moderate Asthma Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biomedical Refrigerators and Freezers Market Value to Reach US$4.28 billion by the End of 2024: Transparency Market Research

Albany – NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The global biomedical refrigerators and ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Upcoming Investor Presentations

author_avatar
NASDAQ Market News

AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3

author_avatar
NASDAQ Market News